A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A Southwest Oncology Group study (Q44158194)
Jump to navigation
Jump to search
scientific article published in February 1995
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A Southwest Oncology Group study |
scientific article published in February 1995 |
Statements
1 reference
A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A Southwest Oncology Group study (English)
1 reference
Dalton WS
1 reference
Crowley JJ
1 reference
Salmon SS
1 reference
Grogan TM
1 reference
Laufman LR
1 reference
Weiss GR
1 reference
Bonnet JD
1 reference
1 February 1995
1 reference
1 reference
75
1 reference
3
1 reference
815-820
1 reference
Identifiers
1 reference
1 reference